Low grade ovarian serous adenocarcinoma
Clinical trials for Low grade ovarian serous adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Low grade ovarian serous adenocarcinoma trials appear
Sign up with your email to follow new studies for Low grade ovarian serous adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple oral drug combo targets two stubborn gynecologic cancers
Disease control Not yet recruitingResearchers are testing a combination of three oral drugs, imlunestrant, abemaciclib, and selinexor, in people with low grade serous ovarian cancer or endometrioid endometrial cancer. The trial enrolls 60 participants in two separate groups, one for each cancer type. Everyone rec…
Matched conditions: LOW GRADE OVARIAN SEROUS ADENOCARCINOMA
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 22, 2026 01:00 UTC
-
Can a Two-Drug combo keep fighting a rare ovarian cancer?
Disease control Not yet recruitingThis study offers continued access to an experimental combination of two oral drugs—avutometinib and defactinib—for people with recurrent low-grade serous ovarian cancer (LGSOC) who have already been benefiting from this treatment in a prior study. The goal is to allow uninterrup…
Matched conditions: LOW GRADE OVARIAN SEROUS ADENOCARCINOMA
Phase 2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC